The company is in discussions to resolve thousands of lawsuits. Participants in the talks value the plan at between $10 billion and $12 billion. Source: NYT > Business – Jan Hoffman
Johnson & Johnson’s Brand Falters Over Its Role in the Opioid Crisis
An Oklahoma court case highlights the health care giant’s role in the epidemic as a leading supplier of opioid ingredients. Source: NYT > Business – Katie Thomas and Tiffany Hsu
A Nun, a Doctor and a Lawyer — and Deep Regret Over the Nation’s Handling of Opioids
In an Appalachian town, an unlikely group of activists recognized the early stages of the deadly drug epidemic, and fought in vain to stem its rise. Source: NYT > Business – Barry Meier
No Pre-Reading, No Rehearsing: How ‘The Weekly’ Kept Its Recreation of Historic Opioid Testimony Authentic
The Times TV show’s producer/director shares the challenges and rewards of bringing to life witness testimony against Purdue Pharma in a way that stayed true to our journalistic principles. Source: NYT > Business – John Pappas
A Secret Opioid Memo That Could Have Slowed an Epidemic
A new TV Show from The New York Times on FX and Hulu. Source: NYT > Business –
New York Subpoenas Banks, Financial Advisers for Sackler Records
The state claims that the Purdue Pharma owners transferred billions of dollars from the company and hid them in offshore partnerships and other entities. Source: NYT > Business – Roni Caryn Rabin